Clinical Trial

Treatment of Systemic Lupus Erythematosus With Human Umbilical Cord Mesenchymal Stem Cells

Name: Treatment of Systemic Lupus Erythematosus With Human Umbilical Cord Mesenchymal Stem Cells — clinical trial record (NCT07041801)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1/2

View on ClinicalTrials.gov →

Summary

This study will investigate the safety and efficacy of allogeneic umbilical cord-derived stem cell therapy in treating patients with moderate to severe systemic lupus erythematosus.

Trial Details

NCT Number	NCT07041801
Lead Sponsor	Shenzhen Beike Bio-Technology Co., Ltd.
Conditions	Systemic Lupus Erythematosus (SLE)
Enrollment	58 participants
Start Date	2025-06-28
Primary Completion	2027-09-05 (estimated)
Study Completion	2027-12-28 (estimated)
Updated on ClinicalTrials.gov	2025-06-27